David Benigson is CEO of Signal AI, a company using AI and media data to help executives cut through noise and drive actionable insights. Risk is no longer a four-letter word—it's a critical factor ...
In this free webinar, gain insight into the key elements to reduce risk for clinical trials. Attendees will learn how Independent Review and Data Analytics in eCOA strengthen endpoint integrity and ...
The US Food and Drug Administration (FDA) on Tuesday issued final guidance meant to assist drug and medical device makers in developing risk-based monitoring strategies for clinical investigations ...
Dublin, June 28, 2024 (GLOBE NEWSWIRE) -- The "GCP Risk Management and Risk-Based Monitoring" training has been added to ResearchAndMarkets.com's offering. Good Clinical Practice (GCP) is a set of ...
Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...
Risk monitoring is the ongoing process of identifying, understanding, assessing, monitoring, managing, and mitigating risks that could adversely affect an organization's operations, value, assets and ...
US and EU officials explained on Wednesday what their respective regulatory agencies look for in clinical trial risk-based monitoring (RBM) and how RBM can impact review times. Under a cooperative ...
Portfolio risk management tools are an essential part of your firm's tech stack. These platforms help you spot risks, compare exposures, and adjust portfolios to match each client's risk tolerance and ...
This post is sponsored by IMARC Research, Inc. Since the August 2011 release of the draft guidance document by the FDA on a risk-based approach to monitoring, there has been a lot of buzz in the ...
Now more than ever, organizations are migrating to the cloud. As different areas of IT -- including storage, applications and networking -- shift to the cloud, IT professionals are using cloud-based ...
Risk-Based Quality Management (RBQM) is a strategic approach in pharmaceutical manufacturing and clinical operations that emphasizes identifying, assessing, and managing risks to product quality and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results